STO Fellows’ Forum (STOFF)

Society for Translational Oncology Fellows' Forum (STOFF) is a 3-day intensive meeting that brings together fellows and junior faculty within 5 years of training completion from the leading medical, surgical, and radiation oncology subspecialty fellowships to educate rising stars on issues around and barriers to successful translational cancer research. STOFF brings together a distinguished faculty of prominent scientists, clinicians, ethicists, industry representatives, and biotech investors as mentors.

The next Society for Translational Oncology Fellows’ Forum will convene January 30 – February 1, 2020, at the Lansdowne in Leesburg, VA.

2018 STOFF

2018 STOFF Agenda (PDF)

Presentation Summaries

Bruce A. Chabner, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Susan Hilsenbeck, PhD
Baylor College of Medicine,
Houston, Texas, USA
 

Stacey Berg, MD
Texas Children’s Cancer Center, Texas Children’s Hospital,
Baylor College of Medicine, Houston, TX, USA
 

Bernardo H.L. Goulart, MD, MS
University of Washington
Seattle Cancer Care Alliance, Seattle, Washington, USA

Keith Flaherty, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA

Ross Levine, MD
Memorial Sloan Kettering Cancer Center,
New York, New York, USA
 

Tatiana Prowell, MD
City of Hope Comprehensive Cancer Center,
Duarte, California, USA
 

Mark W. Duncan, PhD
University of Colorado,
Denver, Colorado, USA
 

Kiran Patel, MD
Janssen Research & Development, LLC,
Raritan, New Jersey, USA
 

Michael Maitland, MD
Schar Cancer Institute, Inova Health System,
Annandale, Virginia, USA
 

Kerry Reynolds, MD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
 

Carlos Ramos, MD
Cleveland Clinic,
Cleveland, Ohio, USA
 

Ryan Corcoran, MD, PhD
Massachusetts General Hospital Cancer Center,
Boston, Massachusetts, USA
 

Neil Hayes, MD
University of Tennessee Health Science Center,
Germantown, Tennessee, USA
 

Acknowledgments

This activity is sponsored by the Society for Translational Oncology. STO gratefully acknowledges the support of the 2018 Fellows’ Forum from:

  • Amgen
  • Janssen
  • CHAAO